Literature DB >> 12214253

Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a.

M Christine Hollander1, Albert J Fornace.   

Abstract

Genomic instability has been a recognized feature of many human tumors for decades. Until recently, however, there was little insight into potential mechanisms for this phenomenon. Recent work has shown first, that increased centrosome numbers (also referred to as centrosome amplification) often accompany genomic instability and second, that when centrosome numbers are increased, cells become genetically unstable. Deletion of Gadd45a leads to centrosome amplification and consequent abnormal mitosis and aneuploidy. Gadd45a is known to be involved in a G2 checkpoint and may be involved in the normal progression from G2 to M and its coordination with S phase events. Whether these functions contribute to prevention of centrosome amplification is being investigated. However, potential mechanisms can be proposed based on known protein associations with Gadd45a, as well as proteins that regulate Gadd45a transcription and are also required for efficient coordination of centrosome duplication and DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214253     DOI: 10.1038/sj.onc.1205774

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Transcriptional responses of cancer-related genes in turbot Scophthalmus maximus and mussels Mytilus edulis exposed to heavy fuel oil no. 6 and styrene.

Authors:  Pamela Ruiz; Amaia Orbea; Jeanette M Rotchell; Miren P Cajaraville
Journal:  Ecotoxicology       Date:  2012-02-04       Impact factor: 2.823

Review 2.  Global analysis of gene expression in mammalian kidney.

Authors:  Olga Soutourina; Lydie Cheval; Alain Doucet
Journal:  Pflugers Arch       Date:  2004-12-21       Impact factor: 3.657

3.  Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation.

Authors:  Farah D Lubin
Journal:  Neurobiol Learn Mem       Date:  2011-03-16       Impact factor: 2.877

4.  Ing1 functions in DNA demethylation by directing Gadd45a to H3K4me3.

Authors:  Andrea Schäfer; Emil Karaulanov; Ulrike Stapf; Gabi Döderlein; Christof Niehrs
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

Review 5.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

Review 6.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

7.  Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.

Authors:  Yehudit Birger; Frédéric Catez; Takashi Furusawa; Jae-Hwan Lim; Marta Prymakowska-Bosak; Katherine L West; Yuri V Postnikov; Diana C Haines; Michael Bustin
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

8.  Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

Authors:  Eddy H J van Roon; Marjo van Puijenbroek; Anneke Middeldorp; Ronald van Eijk; Emile J de Meijer; Dianhdra Erasmus; Kim A D Wouters; Manon van Engeland; Jan Oosting; Frederik J Hes; Carli M J Tops; Tom van Wezel; Judith M Boer; Hans Morreau
Journal:  BMC Cancer       Date:  2010-05-05       Impact factor: 4.430

Review 9.  Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Authors:  Pin Zhuo; Alan M Diamond
Journal:  Biochim Biophys Acta       Date:  2009-03-13

10.  Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity.

Authors:  Sheng-Jia Zhang; Ming Zou; Li Lu; David Lau; Désirée A W Ditzel; Celine Delucinge-Vivier; Yoshinori Aso; Patrick Descombes; Hilmar Bading
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.